Tenax Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
TENX on Nasdaq
Industry
Pharmaceutical Preparations
Location
101 Glen Lennox Drive, Suite 300, Chapel Hill, NC

There are no Buy or Sell transactions made by insiders since 12/22/2023

Tenax Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas Mcgauley Interim CFO Dec 2, 2024
June Sherie Almenoff Director Dec 10, 2024
Lawrence R. Hoffman Interim CFO Jan 11, 2024
Proehl Gerald T Director Dec 10, 2024
Robyn Hunter Director Dec 10, 2024
Eliot M. Lurier Interim CFO Oct 29, 2021
Declan Doogan Director Dec 10, 2024
Stuart Rich Chief Medical Officer, Director Dec 10, 2024
Christopher Thomas Giordano CEO, Director Dec 10, 2024
Anthony A. DiTonno CEO, Director Jul 6, 2021
Michael H. Davidson Director Dec 10, 2024
James Mitchum Director Jun 10, 2021
Armistice Capital, Llc Director May 18, 2022

Recent Insider Transactions by Companies or Individuals for Tenax Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.